Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CareteqASX:CTQ -8.33% 3-1 Month Momentum % is -14.29% as of Jul. 31, 2026. The stock has 6 warning signs investors should review. Among 677 Healthcare Providers & Services companies, Careteq ranks worse than 73.86% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-31), Careteq's 3-1 Month Momentum % is -14.29%.
The industry rank for Careteq's 3-1 Month Momentum % or its related term are showing as below:
ASX:CTQ's 3-1 Month Momentum % is ranked worse than 73.86% of 677
companies
in the Healthcare Providers & Services industry
Industry Median: -3.12
vs ASX:CTQ: -14.29
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Careteq 3-1 Month Momentum % Related Terms
ASX:CTQ vs VEEV, BTSG, HQY: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, Careteq's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careteq 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Careteq's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Careteq's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careteq (ASX:CTQ) has a 3-1 Month Momentum % of -14.29% as of Jul. 31, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Careteq and its competitors. According to the industry distribution chart, Careteq ranks #500 out of 677 companies in the Healthcare Providers & Services industry, placing it in the top 73.9%.
Is Careteq's 3-1 Month Momentum % too high?
Careteq's current 3-1 Month Momentum % is -14.29%. Based on the distribution chart, Careteq ranks #500 out of 677 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Careteq's 3-1 Month Momentum % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Careteq ranks #500 out of 677 companies for 3-1 Month Momentum %. This places Careteq in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Careteq and its competitors. Careteq's current 3-1 Month Momentum % is -14.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Fairly Valued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 10% above its estimated fair value. The current 3-1 Month Momentum % is -14.29%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current 3-1 Month Momentum % is -14.29% as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CTQ has been successfully added to your 
